<p><strong>Metastatic Breast Cancer</strong>: Nab-Paclitaxel is indicated for the treatment of&nbsp;breast cancer&nbsp;after failure of combination chemotherapy for metastatic disease or relapse within 6 months of&nbsp;adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.<br />
<br />
<strong>Non-Small Cell Lung Cancer</strong>: Nab-Paclitaxel is indicated for the first-line treatment of locally advanced or metastatic&nbsp;non-small cell lung cancer, in combination with carboplatin, in patients who are not candidates for curative surgery or&nbsp;radiation therapy.<br />
<br />
<strong>Adenocarcinoma Of The Pancreas</strong>: Nab-Paclitaxel is indicated for the first-line treatment of patients with metastatic&nbsp;adenocarcinoma&nbsp;of the pancreas, in combination with gemcitabine.</p>